Your browser doesn't support javascript.
loading
Pegvisomant and not somatostatin receptor ligands (SRLs) is first-line medical therapy for acromegaly.
van der Lely, Aart J; Kuhn, Emmanuelle; Muhammad, Ammar; Coopmans, Eva C; Neggers, Sebastian J; Chanson, Philippe.
Afiliação
  • van der Lely AJ; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
  • Kuhn E; Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, Le Kremlin Bicêtre, France.
  • Muhammad A; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
  • Coopmans EC; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
  • Neggers SJ; Division of Endocrinology and the Rotterdam Pituitary Centre, Department of Medicine, Erasmus University MC, Rotterdam, The Netherlands.
  • Chanson P; Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, Le Kremlin Bicêtre, France.
Eur J Endocrinol ; 182(6): D17-D29, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32234975

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acromegalia / Receptores da Somatotropina / Hormônio do Crescimento Humano Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acromegalia / Receptores da Somatotropina / Hormônio do Crescimento Humano Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article